Research Objectives

Stock Quotes for Research Objectives (1)
News Articles for Research Objectives (19)

Stock Quotes for Research Objectives top ^

ocl - Objective Corporation Limited

Industry: Software - Application
Sector: Technology
Stock Style: Small Core

View Price Quote for ocl - Objective Corporation Limited

Sign-up for ocl investment picks

News Articles for Research Objectives top ^

2013/2/27

MicroVision Announces 2012 Results and 2013 Objectives

MicroVision, Inc. (NASDAQ:MVIS) , a leader in innovative ultra-miniature projection display technology, today announced its 2012 operating and financial results and an overview of its 2013 business objectives.

View more MicroVision Announces 2012 Results and 2013 Objectives analysis

Sign-up for MicroVision Announces 2012 Results and 2013 Objectives investment picks

2013/5/29

States Object to Swipe-Fee Settlement

--States say settlement could prevent them from bringing suits or other actions on behalf of their citizens --Wal-Mart, Target, Home Depot, Gap and other merchants have opposed the deal --Settlement would end litigation filed in 2005 over Visa and MasterCard transaction fees Numerous U.S. states are joining big-box retailers and merchant trade groups in opposing a $7.25 billion class-action settlement over Visa Inc.'s (V) and MasterCard Inc.'s (MA) transaction-processing fees.

View more States Object to Swipe-Fee Settlement analysis

Sign-up for States Object to Swipe-Fee Settlement investment picks

2013/5/29

UPDATE: States Object to Swipe-Fee Settlement With Visa, MasterCard

--States say settlement could prevent them from bringing suits or other actions on behalf of their citizens --Wal-Mart, Target, Home Depot, Gap and other merchants have opposed the deal --Settlement would end litigation filed in 2005 over Visa and MasterCard transaction fees (Adds comments from Wal-Mart and Starbucks filings, comments from outside attorneys and new details throughout.) By Andrew R.

View more UPDATE: States Object to Swipe-Fee Settlement With Visa, MasterCard analysis

Sign-up for UPDATE: States Object to Swipe-Fee Settlement With Visa, MasterCard investment picks

2013/4/10

Erdene Announces Wind-Up of the Mongolian Coal Alliance and Updates Strategic Objectives

http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0865939001&sourceType=1 http://www.ccnmatthews.com/logos/20080515-erd1.jpg HALIFAX, NOVA SCOTIA --

View more Erdene Announces Wind-Up of the Mongolian Coal Alliance and Updates Strategic Objectives analysis

Sign-up for Erdene Announces Wind-Up of the Mongolian Coal Alliance and Updates Strategic Objectives investment picks

2013/4/25

Investors Group announces fund mergers and objective changes

Investors Group announces fund mergers and objective changes Canada NewsWire WINNIPEG , April 25, 2013 /CNW/ - Investors Group today announced proposed changes to its fund offering involving nine fund mergers and proposed changes to the investment objectives of ten Corporate Class Funds.

View more Investors Group announces fund mergers and objective changes analysis

Sign-up for Investors Group announces fund mergers and objective changes investment picks

2013/5/24

Global Alumina Announces Receipt of No Objection Letter Regarding Sale of Its Interests in Guinea Alumina Corporation

Global Alumina Announces Receipt of No Objection Letter Regarding Sale of Its Interests in Guinea Alumina Corporation Canada NewsWire TORONTO , May 24, 2013 /CNW/ - Global Alumina Corporation (TSX: GLA.U) (the "Company" or "Global Alumina") is pleased to announce that the Ministry of Mines and Geology of the Republic of Guinea has issued a no objection letter (the "NOL") in connection with the previously announced sale by the Company of all of its interests in Guinea Alumina Corporation Limited (" Guinea Alumina") to DM GAV Limited ("DM GAV"). The receipt of the NOL satisfies a material condition precedent to the completion of the transaction pursuant to the terms of the share purchase agreement entered into by the Company and DM GAV (the "SPA"). Completion of the transaction remains subject to, among other things, completion of DM GAV's acquisition of BHP Broken Hill Proprietary Company PTY Limited's interests in Guinea Alumina and to

View more Global Alumina Announces Receipt of No Objection Letter Regarding Sale of Its Interests in Guinea Alumina Corporation analysis

Sign-up for Global Alumina Announces Receipt of No Objection Letter Regarding Sale of Its Interests in Guinea Alumina Corporation investment picks

2013/5/29

State AGs Object To Swipe-Fee Settlement With Visa, MasterCard

Numerous U.S. states are joining big-box retailers and merchant trade groups in objecting to a $7.25 billion class- action settlement over Visa Inc.'s (V) and MasterCard Inc.'s (MA) transaction-processing fees.

View more State AGs Object To Swipe-Fee Settlement With Visa, MasterCard analysis

Sign-up for State AGs Object To Swipe-Fee Settlement With Visa, MasterCard investment picks

2013/4/9

Health Management Associates, Inc. Previews First Quarter 2013 Results and Updates 2013 Objectives

Health Management Associates, Inc. (NYSE:HMA) announced today its expected, unaudited results of operations for the first quarter ended March 31, 2013.

View more Health Management Associates, Inc. Previews First Quarter 2013 Results and Updates 2013 Objectives analysis

Sign-up for Health Management Associates, Inc. Previews First Quarter 2013 Results and Updates 2013 Objectives investment picks

2013/4/30

China United Insurance Service Outlines Strategic Objectives

-- Company Launches New Corporate and Investor Relations Website --

View more China United Insurance Service Outlines Strategic Objectives analysis

Sign-up for China United Insurance Service Outlines Strategic Objectives investment picks

2013/2/28

Clovis Oncology Announces 2012 Operating Results and 2013 Objectives

Clovis Oncology , Inc. (NASDAQ:CLVS) today reported financial results for its quarter and year ended December 31, 2012, and provided an update on the expected milestones for its clinical development programs for 2013.

View more Clovis Oncology Announces 2012 Operating Results and 2013 Objectives analysis

Sign-up for Clovis Oncology Announces 2012 Operating Results and 2013 Objectives investment picks

2013/3/14

Huntington Bancshares Receives No Objection From The Federal Reserve For Proposed Capital Actions, Including An Increase Of The Quarterly Dividend To $0.05 Per Common Share And The Repurchase Of Up To $227 Million Of Common Stock

Huntington Bancshares Incorporated (NASDAQ: HBAN; www.huntington.com ) was notified by the Federal Reserve that it had no objection to Huntington's proposed capital actions included in Huntington's capital plan submitted to the Federal Reserve in January of this year.

View more Huntington Bancshares Receives No Objection From The Federal Reserve For Proposed Capital Actions, Including An Increase Of The Quarterly Dividend To $0.05 Per Common Share And The Repurchase Of Up To $227 Million Of Common Stock analysis

Sign-up for Huntington Bancshares Receives No Objection From The Federal Reserve For Proposed Capital Actions, Including An Increase Of The Quarterly Dividend To $0.05 Per Common Share And The Repurchase Of Up To $227 Million Of Common Stock investment picks

2013/3/14

Wells Fargo Receives No Objection to its 2013 Capital Plan

Wells Fargo & Company (NYSE: WFC) announced today that the Federal Reserve Board (FRB) has not objected to the Company’s 2013 Capital Plan under the recently concluded Comprehensive Capital Analysis and Review (CCAR) of the nation’s largest banks.

View more Wells Fargo Receives No Objection to its 2013 Capital Plan analysis

Sign-up for Wells Fargo Receives No Objection to its 2013 Capital Plan investment picks

2013/3/14

U.S. Bancorp Receives Results of Comprehensive Capital Analysis and Review; Federal Reserve Did Not Object to Company's Capital Distribution Plan

Today the Federal Reserve disclosed the results of the 2013 Comprehensive Capital Analysis and Review (“CCAR”). After a review of the Company’s CCAR results, the Federal Reserve did not object to the Company’s plan to increase its capital distributions over the next four fiscal quarters.

View more U.S. Bancorp Receives Results of Comprehensive Capital Analysis and Review; Federal Reserve Did Not Object to Company's Capital Distribution Plan analysis

Sign-up for U.S. Bancorp Receives Results of Comprehensive Capital Analysis and Review; Federal Reserve Did Not Object to Company's Capital Distribution Plan investment picks

2013/4/3

Xyratex Enters Into Strategic Relationship with AMD to Create Solutions Tailored for Apache Hadoop and Object Storage

Top-rated Storage Technology from Xyratex with AMD's SeaMicro SM15000™ Server Creates Ultra-Dense, Power-Efficient Solution HAVANT, United Kingdom , April 3, 2013 /PRNewswire/ -- Xyratex Ltd (Nasdaq: XRTX) , a leading provider of data storage technology, today announced that Advanced Micro Devices, Inc. (NYSE: AMD) has chosen Xyratex as a strategic supplier.

View more Xyratex Enters Into Strategic Relationship with AMD to Create Solutions Tailored for Apache Hadoop and Object Storage analysis

Sign-up for Xyratex Enters Into Strategic Relationship with AMD to Create Solutions Tailored for Apache Hadoop and Object Storage investment picks

2013/4/25

Top-Line Data Show Celecoxib Met Primary Objective In Clinical Trial To Evaluate The Effects On Blood Pressure In Pediatric Patients With Juvenile Idiopathic Arthritis

Pfizer Inc. (NYSE: PFE) today announced top-line results for a Phase 4 clinical trial in which the primary objective was to measure blood pressure (hypertension) among pediatric patients with Juvenile Idiopathic Arthritis (JIA; also known as Juvenile Rheumatoid Arthritis or JRA) taking celecoxib (Celebrex) capsules or naproxen.

View more Top-Line Data Show Celecoxib Met Primary Objective In Clinical Trial To Evaluate The Effects On Blood Pressure In Pediatric Patients With Juvenile Idiopathic Arthritis analysis

Sign-up for Top-Line Data Show Celecoxib Met Primary Objective In Clinical Trial To Evaluate The Effects On Blood Pressure In Pediatric Patients With Juvenile Idiopathic Arthritis investment picks

2013/4/25

Essilor Confirms 2013 Objectives; 1Q Revenue Stable

French opthalmic optics company Essilor SA (EI.FR) said Thursday it is maintaining its objective for revenue to increase by more than 7% in 2013 although revenue in the first quarter of the year was stable.

View more Essilor Confirms 2013 Objectives; 1Q Revenue Stable analysis

Sign-up for Essilor Confirms 2013 Objectives; 1Q Revenue Stable investment picks

2013/4/29

Four in Ten Marketing Executives Unprepared to Meet Objectives Due to Lack of Funding and Internal Inefficiencies, Accenture Study Finds

Four in 10 top marketing executives say they are not well prepared to meet their objectives, citing a lack of funding and inefficient business practices as the main impediments to improved performance, according to global research by Accenture (NYSE:ACN) .

View more Four in Ten Marketing Executives Unprepared to Meet Objectives Due to Lack of Funding and Internal Inefficiencies, Accenture Study Finds analysis

Sign-up for Four in Ten Marketing Executives Unprepared to Meet Objectives Due to Lack of Funding and Internal Inefficiencies, Accenture Study Finds investment picks

2013/5/24

Global Alumina Announces Receipt of No Objection Letter Regarding Sale of Its Interests in Guinea Alumina Corporation

TORONTO , May 24, 2013 /PRNewswire/ -- Global Alumina Corporation (TSX: GLA.U) (the "Company" or "Global Alumina") is pleased to announce that the Ministry of Mines and Geology of the Republic of Guinea has issued a no objection letter (the "NOL") in connection with the previously announced sale by the Company of all of its interests in Guinea Alumina Corporation Limited ("Guinea Alumina") to DM GAV Limited ("DM GAV"). The receipt of the NOL satisfies a material condition precedent to the completion of the transaction pursuant to the terms of the share purchase agreement entered into by the Company and DM GAV (the "SPA"). Completion of the transaction remains subject to, among other things, completion of DM GAV's acquisition of BHP Broken Hill Proprietary Company PTY Limited's interests in Guinea Alumina and to regulatory and shareholder approvals.

View more Global Alumina Announces Receipt of No Objection Letter Regarding Sale of Its Interests in Guinea Alumina Corporation analysis

Sign-up for Global Alumina Announces Receipt of No Objection Letter Regarding Sale of Its Interests in Guinea Alumina Corporation investment picks

2013/2/5

Aflac Incorporated Announces Fourth Quarter Results, 2012 EPS In Line With Guidance And Objective, Affirms 2013 Operating EPS Target, Declares First Quarter Cash Dividend

COLUMBUS, Ga.

View more Aflac Incorporated Announces Fourth Quarter Results, 2012 EPS In Line With Guidance And Objective, Affirms 2013 Operating EPS Target, Declares First Quarter Cash Dividend analysis

Sign-up for Aflac Incorporated Announces Fourth Quarter Results, 2012 EPS In Line With Guidance And Objective, Affirms 2013 Operating EPS Target, Declares First Quarter Cash Dividend investment picks

Start Premium Trial

P	F	Fund Financial Data (13,000+ funds)
P	F	Stock Financial Data (7,000+ stocks)
P	F	Stock and Fund Screeners (basic)
P	F	Investing Articles and Market Commentary
P	F	Articles Archive (>30 days)
P	F	Discuss (dozens of stock, fund, bond, and general bulletin boards)
P	F	Portfolio Manager (basic)
P	F	Morningstar Investment Classroom
P	F	Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P		Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P		Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P		Morningstar Stock and Fund Stewardship Grades
P		Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P		Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P		Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P		Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P		Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P		Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar

Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.

Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.

Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.

Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.

Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.

Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.